APA (7th ed.) Citation

Benninga, M. A., Heyman, M. B., Otley, A., Meij, T. d., Jonge, W. J. d., Verburgt, C. M., . . . Limbergen, J. E. V. (2023). Personalised azithromycin+metronidazole (PAZAZ), in combination with standard induction therapy, to achieve a faecal microbiome community structure and metagenome changes associated with sustained remission in paediatric Crohn’s disease (CD): Protocol of a pilot study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Benninga, Marc A., et al. Personalised Azithromycin+metronidazole (PAZAZ), in Combination with Standard Induction Therapy, to Achieve a Faecal Microbiome Community Structure and Metagenome Changes Associated with Sustained Remission in Paediatric Crohn’s Disease (CD): Protocol of a Pilot Study. BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Benninga, Marc A., et al. Personalised Azithromycin+metronidazole (PAZAZ), in Combination with Standard Induction Therapy, to Achieve a Faecal Microbiome Community Structure and Metagenome Changes Associated with Sustained Remission in Paediatric Crohn’s Disease (CD): Protocol of a Pilot Study. BMJ Publishing Group, 2023.